Skip to menu Skip to content Skip to footer
Professor Craig Munns
Professor

Craig Munns

Email: 
Phone: 
+61 7 3069 7362

Overview

Background

Professor Craig Munns is the Mayne Professor of Paediatrics and Director of the Child Health Research Centre, The University of Queensland. Professor Munns is also a Senior Medical Officer in Paediatric Endocrinology and Diabetes at Queensland Children’s Hospital. He graduated from The University of Queensland, before training in paediatrics and endocrinology at The Royal Children’s Hospital, Brisbane. Professor Munns completed his PhD in paediatric growth disorders through UQ. He then undertook a post-doctoral fellowship in paediatric genetic bone disorders at The Shriners Hospital for Children, Montreal, Canada. From 2004 to 2021, Prof Munns was Senior Staff Specialist in Genetic and Metabolic Bone Disorders and Paediatric Endocrinologist at The Children’s Hospital at Westmead, Sydney. He also undertook roles as Clinical Program Director, Division of Diagnostic Services and Clinical Trials Lead at Kids Research. As Clinical Trials Lead his focus was on developing a research-intensive health system and introducing advanced therapeutics.

Professor Munns is an international expert in paediatric musculoskeletal disorders. His primary clinical and research interests are in diagnosis and management of primary and secondary bone disorders, including osteogenesis imperfecta, hypophosphataemic rickets, disuse osteoporosis and nutritional rickets. He has undertaken a wide range of investigator initiated and sponsored clinical trials, authored international consensus documents and has supervised numerous PhD and Masters students. Prof Munns is actively involved in national and international scientific societies. He was treasurer of Asia Pacific Paediatric Endocrine Society, is the inaugural treasurer of the International Society of Children’s Bone Health and has chaired the program organising committees Australasian Paediatric Endocrine Group, Australian and New Zealand Bone and Mineral Society and International Conference of Children’s Bone Health.

Availability

Professor Craig Munns is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Faculty of Medicine, The University of Queensland
  • Doctor of Philosophy of Paediatrics and Reproductive Medicine, The University of Queensland
  • Fellow, Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Paediatric Musculoskeletal Disorders

    Primary and secondary osteoporosis; Genetic rickets (X-linked hypophosphataemia); Nutritional rickets; Focal bone tumours (Giant cell granuloma, Aneurismal bone cysts); Early detection of disease; Bone density assessment

  • Clinical Trials

    Investigator initiated; Pharmaceutical sponsored; Gene therapy

Research impacts

Professor Munns has developed international consensus guidelines on the prevention and treatment of nutritional rickets. These guidelines have the potential to irradicate this potentially devastating, fully preventable childhood disorder. He has also developed numerous clinical guidelines for the management of paediatric bone disorders such as osteoporosis, X-linked hypophosphataemia, giant cell granuloma and aneurismal bone cysts.

Works

Search Professor Craig Munns’s works on UQ eSpace

190 works between 2000 and 2025

21 - 40 of 190 works

2023

Journal Article

Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document

Vanderniet, Joel A., Szymczuk, Vivian, Högler, Wolfgang, Beck-Nielsen, Signe S., Uday, Suma, Merchant, Nadia, Crane, Janet L., Ward, Leanne M., Boyce, Alison M. and Munns, Craig F. (2023). Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document. The Journal of Clinical Endocrinology and Metabolism, 109 (5), 1371-1382. doi: 10.1210/clinem/dgad657

Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document

2023

Journal Article

Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

Pittet, Laure F., Moore, Cecilia L., McDonald, Ellie, Barry, Simone, Bonten, Marc, Campbell, John, Croda, Julio, Dalcolmo, Margareth, Davidson, Andrew, Douglas, Mark W., Gardiner, Kaya, Gwee, Amanda, Jardim, Bruno, Lacerda, Marcus V.G., Lucas, Michaela, Lynn, David J., Manning, Laurens, de Oliveira, Roberto D., Perrett, Kirsten P., Prat-Aymerich, Cristina, Richmond, Peter C., Rocha, Jorge L., Rodriguez-Baño, Jesus, Warris, Adilia, Wood, Nicholas J., Messina, Nicole L., Curtis, Nigel, Jamieson, Tenaya, Messina, Nicole ... Venton, Tamsin (2023). Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial. eClinicalMedicine, 64 102203, 102203. doi: 10.1016/j.eclinm.2023.102203

Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

2023

Journal Article

Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: Results from the Australian and the New Zealand Paediatric Surveillance Units survey

Sandy, Jessica L., Nunez, Carlos, Wheeler, Benjamin J., Jefferies, Craig, Morris, Anne, Siafarikas, Aris, Rodda, Christine P., Simm, Peter, Biggin, Andrew, Aum, Sonya, Elliot, Elizabeth J. and Munns, Craig F. (2023). Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: Results from the Australian and the New Zealand Paediatric Surveillance Units survey. Bone, 173 116791, 116791. doi: 10.1016/j.bone.2023.116791

Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: Results from the Australian and the New Zealand Paediatric Surveillance Units survey

2023

Journal Article

Vitamin D testing in children and adolescents in Victoria, Australia: are testing practices in line with global recommendations?

Zurynski, Yvonne, Munns, Craig Frank, Sezgin, Gorkem, Imai, Chisato and Georgiou, Andrew (2023). Vitamin D testing in children and adolescents in Victoria, Australia: are testing practices in line with global recommendations?. Archives of Disease in Childhood, 108 (9), 742-747. doi: 10.1136/archdischild-2022-325000

Vitamin D testing in children and adolescents in Victoria, Australia: are testing practices in line with global recommendations?

2023

Journal Article

Serum 1,25-dihydroxyvitamin D levels in the diagnosis and pathogenesis of nutritional rickets – a multivariable re-analysis of a case-control study

Fischer, Philip R., Sempos, Christopher T., Pettifor, John M., Fraser, David R., Munns, Craig F., Durazo-Arvizu, Ramon A. and Thacher, Tom D. (2023). Serum 1,25-dihydroxyvitamin D levels in the diagnosis and pathogenesis of nutritional rickets – a multivariable re-analysis of a case-control study. The American Journal of Clinical Nutrition, 117 (5), 998-1004. doi: 10.1016/j.ajcnut.2023.02.011

Serum 1,25-dihydroxyvitamin D levels in the diagnosis and pathogenesis of nutritional rickets – a multivariable re-analysis of a case-control study

2023

Journal Article

Randomized trial of BCG vaccine to protect against Covid-19 in health care workers

Pittet, Laure F., Messina, Nicole L., Orsini, Francesca, Moore, Cecilia L., Abruzzo, Veronica, Barry, Simone, Bonnici, Rhian, Bonten, Marc, Campbell, John, Croda, Julio, Dalcolmo, Margareth, Gardiner, Kaya, Gell, Grace, Germano, Susie, Gomes-Silva, Adriano, Goodall, Casey, Gwee, Amanda, Jamieson, Tenaya, Jardim, Bruno, Kollmann, Tobias R., Lacerda, Marcus V.G., Lee, Katherine J., Lucas, Michaela, Lynn, David J., Manning, Laurens, Marshall, Helen S., McDonald, Ellie, Munns, Craig F., Nicholson, Suellen ... Curtis, Nigel (2023). Randomized trial of BCG vaccine to protect against Covid-19 in health care workers. New England Journal of Medicine, 388 (17), 1582-1596. doi: 10.1056/nejmoa2212616

Randomized trial of BCG vaccine to protect against Covid-19 in health care workers

2023

Journal Article

Burosumab versus phosphate/active vitamin D in pediatric x-linked hypophosphatemia: a sub-group analysis by dose level

Imel, Erik A, Glorieux, Francis H, Whyte, Michael P, Portale, Anthony A, Munns, Craig F, Nilsson, Ola, Simmons, Jill H, Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Pitukcheewanont, Pisit, Sochett, Etienne, Högler, Wolfgang, Muroya, Koji, Tanaka, Hiroyuki, Gottesman, Gary S, Biggin, Andrew, Perwad, Farzana, Chen, Angel, Roberts, Mary Scott and Ward, Leanne M (2023). Burosumab versus phosphate/active vitamin D in pediatric x-linked hypophosphatemia: a sub-group analysis by dose level. The Journal of Clinical Endocrinology and Metabolism, 108 (11), 2990-2998. doi: 10.1210/clinem/dgad230

Burosumab versus phosphate/active vitamin D in pediatric x-linked hypophosphatemia: a sub-group analysis by dose level

2023

Journal Article

Asia-Pacific consensus recommendations on x-linked hypophosphatemia: diagnosis, multidisciplinary management, and transition from pediatric to adult care

Munns, Craig F, Yoo, Han-Wook, Jalaludin, Muhammad Yazid, Vasanwala, Rashida, Chandran, Manju, Rhee, Yumie, But, Wai Man, Kong, Alice Pik-Shan, Su, Pen-Hua, Numbenjapon, Nawaporn, Namba, Noriyuki, Imanishi, Yasuo, Clifton-Bligh, Roderick J, Luo, Xiaoping and Xia, Weibo (2023). Asia-Pacific consensus recommendations on x-linked hypophosphatemia: diagnosis, multidisciplinary management, and transition from pediatric to adult care. JBMR Plus, 7 (6) e10744, e10744. doi: 10.1002/jbm4.10744

Asia-Pacific consensus recommendations on x-linked hypophosphatemia: diagnosis, multidisciplinary management, and transition from pediatric to adult care

2023

Journal Article

Surgical management and denosumab for aneurysmal bone cysts of the spine in an Australian tertiary paediatric centre

Vanderniet, Joel A., Tsinas, Dionysios, Wall, Christie-Lee, Girgis, Christian M., London, Kevin, Keane, Corinne, Briody, Julie, Hibbert, Sally, Poon, Myra, Padhye, Bhavna, Biggin, Andrew, Dalla-Pozza, Luciano, Gray, Randolph J. and Munns, Craig F. (2023). Surgical management and denosumab for aneurysmal bone cysts of the spine in an Australian tertiary paediatric centre. Calcified Tissue International, 112 (5), 592-602. doi: 10.1007/s00223-023-01068-1

Surgical management and denosumab for aneurysmal bone cysts of the spine in an Australian tertiary paediatric centre

2023

Journal Article

Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density

O'Donohue, Alexandra K., Xiao, Ya, Lee, Lucinda R., Schofield, Timothy, Cheng, Tegan L., Munns, Craig F., Baldock, Paul A. and Schindeler, Aaron (2023). Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density. Bone, 167 116636, 1-9. doi: 10.1016/j.bone.2022.116636

Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density

2023

Journal Article

Craniosynostosis in patients with x‐linked hypophosphataemia: a review

Munns, Craig F, Maguire, Edward P, Williams, Angela, Wood, Sue and Biggin, Andrew (2023). Craniosynostosis in patients with x‐linked hypophosphataemia: a review. JBMR Plus, 7 (5) e10728, e10728. doi: 10.1002/jbm4.10728

Craniosynostosis in patients with x‐linked hypophosphataemia: a review

2023

Journal Article

Expanding the phenotype of Bruck syndrome: severe limb deformity, arthrogryposis, congenital cardiac disease and pulmonary hemorrhage

Sandy, Jessica L., Perez, Darazel, Goh, Shuxiang, Forsey, Jonathan, Rajagopalan, Sulekha, Trivedi, Amit and Munns, Craig F. (2023). Expanding the phenotype of Bruck syndrome: severe limb deformity, arthrogryposis, congenital cardiac disease and pulmonary hemorrhage. American Journal of Medical Genetics, Part A, 191 (1), 265-270. doi: 10.1002/ajmg.a.63007

Expanding the phenotype of Bruck syndrome: severe limb deformity, arthrogryposis, congenital cardiac disease and pulmonary hemorrhage

2022

Journal Article

Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand

Adaikina, Alena, Derraik, José G B, Power, Lisa C, Grady, Gina O, Munns, Craig F, Hofman, Paul L and Gusso, Silmara (2022). Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand. Neuromuscular Disorders, 32 (10), 820-828. doi: 10.1016/j.nmd.2022.07.398

Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand

2022

Journal Article

Childhood type 1 diabetes is associated with abnormal bone development

Vora, Komal Ashokbhai, Munns, Craig F., Donaghue, Kim C., Craig, Maria E., Briody, Julie and Benitez-Aguirre, Paul (2022). Childhood type 1 diabetes is associated with abnormal bone development. Pediatric Diabetes, 23 (6), 773-782. doi: 10.1111/pedi.13367

Childhood type 1 diabetes is associated with abnormal bone development

2022

Conference Publication

Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period

Padidela, Raja, Whyte, Michael P., Glorieux, Francis H., Munns, Craig F., Ward, Leanne M., Nilsson, Ola, Portale, Anthony A., Simmons, Jill H., Namba, Noriyuki, Cheong, Hae Il, Pitukcheewanont, Pisit, Sochett, Etienne, Hoegler, Wolfgang, Muroya, Koji, Gottesman, Gary S., Biggin, Andrew, Perwad, Farzana, Williams, Angela, Nixon, Annabel, Sun, Wei, Chen, Angel, Skrinar, Alison and Imel, Erik A. (2022). Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period. BASEL: KARGER.

Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period

2022

Journal Article

Effect of burosumab compared with conventional therapy on younger vs older children with x-linked hypophosphatemia

Ward, Leanne M., Glorieux, Francis H., Whyte, Michael P., Munns, Craig F., Portale, Anthony A., Högler, Wolfgang, Simmons, Jill H., Gottesman, Gary S., Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Nilsson, Ola, Mao, Meng, Chen, Angel, Skrinar, Alison, Roberts, Mary Scott and Imel, Erik A. (2022). Effect of burosumab compared with conventional therapy on younger vs older children with x-linked hypophosphatemia. The Journal of Clinical Endocrinology and Metabolism, 107 (8), e3241-e3253. doi: 10.1210/clinem/dgac296

Effect of burosumab compared with conventional therapy on younger vs older children with x-linked hypophosphatemia

2022

Journal Article

Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre

Vanderniet, Joel A., Wall, Christie-Lee, Mullins, Anna, London, Kevin, Lim, Lydia, Hibbert, Sally, Briody, Julie, Padhye, Bhavna, Poon, Myra, Biggin, Andrew, Dalla-Pozza, Luciano and Munns, Craig F. (2022). Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre. Bone, 159 116395, 1-9. doi: 10.1016/j.bone.2022.116395

Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre

2022

Journal Article

Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta

Lee, Lucinda R., Holman, Aimee E., Li, Xiaoying, Vasiljevski, Emily R., O'Donohue, Alexandra K., Cheng, Tegan L., Little, David G., Schindeler, Aaron, Biggin, Andrew and Munns, Craig F. (2022). Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta. Bone, 159 116378, 1-12. doi: 10.1016/j.bone.2022.116378

Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta

2022

Journal Article

Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab

Sandy, Jessica L., Simm, Peter J., Biggin, Andrew, Rodda, Christine P., Wall, Christie-Lee, Siafarikas, Aris and Munns, Craig F. (2022). Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab. Journal of Paediatrics and Child Health, 58 (5), 762-768. doi: 10.1111/jpc.15976

Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab

2022

Journal Article

Clinical and radiologic response of central giant cell granuloma to denosumab: A 6-year prospective observational study

Rhou, Yoon Ji Jina, Wang, Che-Jen, Nguyen, Minh, Vanderniet, Joel A., Munns, Craig F., Coleman, Hedley, Kim, James, Holmes-Walker, Deborah Jane, Lim, Lydia and Girgis, Christian M. (2022). Clinical and radiologic response of central giant cell granuloma to denosumab: A 6-year prospective observational study. Calcified Tissue International, 110 (4), 464-474. doi: 10.1007/s00223-021-00935-z

Clinical and radiologic response of central giant cell granuloma to denosumab: A 6-year prospective observational study

Funding

Current funding

  • 2024 - 2026
    The 360-Kids community Network to support children with neurodevelopment challenges (HERA 2.0 partnership)
    Health and Wellbeing Queensland
    Open grant
  • 2024 - 2028
    Klinefelter Syndrome Registry
    William Ivers Memorial Fund
    Open grant
  • 2023 - 2027
    Australian Cerebral Palsy Musculoskeletal Health Network
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2026
    Children with Lower Limb Pain (CLLiP): Working with families, community and health care provider's to improve outcomes (MRFF Chronic Musculoskeletal administered by Monash University)
    Monash University
    Open grant

Supervision

Availability

Professor Craig Munns is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Tele-Dialysis in community settings: Is it feasible, safe and effective?

    Principal Advisor

  • Doctor Philosophy

    Urinary stem cells for diagnosis and characterisation of primary bone disorders

    Principal Advisor

    Other advisors: Professor Di Yu

  • Doctor Philosophy

    Food Allergy Diagnosis and Management in Late Adolescence

    Associate Advisor

    Other advisors: Associate Professor Jennifer Koplin

Media

Enquiries

Contact Professor Craig Munns directly for media enquiries about:

  • Paediatric Bone
  • Rickets
  • Vitamin D

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au